Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy <i>versus</i> liposomal cytarabine and daunorubicin

Therapy-related acute myeloid leukemia (t-AML) and AML with myelodysplasia-related changes (AML-MRC) are associated with poor outcomes. The liposomal formulation of cytarabine and daunorubicin (CPX-351) improved complete remission (CR) and CR with incomplete hematologic recovery (CRi) rates and ove...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Dimitrios Kotsos, Patrycja Gradowska, Sjoerd J.F. Hermans, Thomas Pabst, Johan Maertens, Markus Manz, Dimitri A. Breems, Bjorn T. Gertsen, Soren Lehmann, Bart J. Biemond, Berna H. Beverloo, Peter J.M. Valk, Jeroen J.W.M. Janssen, Gert Ossenkoppele, Bob Löwenberg, Gerwin Huls, Marc H.G.P. Raaijmakers, Jurjen Versluis.
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Ferrata Storti Foundation 2026-03-01
Seri Bilgileri:	Haematologica
Online Erişim:	https://haematologica.org/article/view/13423
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!